ECS Botanics Reports Positive Q1 FY27 Cash Flow and Sales Growth
Key points
- Fifth consecutive quarter of positive operating cash flow at $243k
- Branded B2C sales increased 23.9% YoY to $3.91 million
- OzSun flower sales grew 44.5% YoY to $1.33 million
- Executed UK distribution agreement with Curaleaf Laboratories
- Received regulatory approval for first flower registration in Poland
Full summary
ECS Botanics Holdings Ltd (ASX: ECS) reported positive operating cash flow of $243k for Q1 FY27, marking the fifth consecutive quarter of positive cash flow. Branded B2C sales increased 23.9% YoY to $3.91 million, with total sales at $5.49 million. OzSun flower sales grew 44.5% YoY to $1.33 million. The company also announced a distribution agreement with Curaleaf Laboratories for the UK market and received regulatory approval for its first flower registration in Poland.
Outlook
ECS plans to continue growing branded B2C sales, expand international presence, and maintain disciplined cost management for the remainder of FY27.
Summary generated by a large language model. Please interpret with care.